Phillips-Medisize, in collaboration with its customer, Ascendis Pharma, was recently recognized with a third industry award for the Skytrofa Auto-Injector. The Red Dot Award recognizes the drug ...

The Aidaptus ® disposable auto-injector platform, designed by Owen Mumford, will be jointly offered to global biopharma companies to support their drug development programs with engineering and ...

Study met primary end point and demonstrated successful subcutaneous administration of a 10 mL biologic co-formulated with ENHANZE® in 30 seconds using Halozyme's proprietary high-volume auto-injector ...

The growth hormone therapy market had become crowded and static. With little variety in the efficacy of drugs or treatments on offer, Merck Serono wanted to develop a device that would achieve ...

GAITHERSBURG, Md., Sept. 25, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that it has been awarded approximately $20 million to develop and manufacture an ...

Xeris Pharmaceuticals last year snared approval for its first drug, a shelf-stable glucagon injector for hypoglycemia. Now it's deploying its formulation tech to hit another target—epilepsy—and the ...

Gvoke HypoPen allows patients to inject glucagon by themselves, and quickly, unlike Gvoke prefilled syringes—or rival emergency glucagon kits—which require help from someone else. (Business Wire) () ...

Skytrofa is administered as a once weekly injection. It comes as a powder in cartridges that you load into an auto-injector device. The dosage of Skytrofa will vary based on your age, weight, and ...